Product Information
Name:EG 00229
Brand:Biosynth
Description:EG 00229 is a potential anti-cancer agent that belongs to the class of nitrobenzothiadiazoles. It has been shown to inhibit the vascular endothelial growth factor receptor (VEGFR). This drug can be used for the treatment of cancer, as it has been shown to suppress tumor growth and metastasis in in vitro and in vivo models. EG 00229 has been shown to interact with tissues and cells, which might lead to an increased risk of certain side effects. EG 00229 also interacts with other pharmaceuticals via inhibition or induction of hepatic enzymes. EG 00229 inhibits tumor angiogenesis by blocking VEGFR and therefore inhibits tumor growth and metastasis.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:497.6 g/mol
Formula:C17H19N7O5S3
Purity:Min. 95%
Technical inquiry about: EG 00229
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.